Texas A&M Testing COVID-19 Vaccine Candidates For iBio, Inc.

A team of scientists at Texas A&M University is working on two COVID-19 vaccine candidates that could be mass produced quickly in modified tobacco plants. The team is led by Dr. James Samuel, a regents’ professor and the head of the Department of Microbial Pathogenesis and Immunology at the College of Medicine. Samuel discusses the experiments with John Sharp, chancellor of The Texas A&M…

Premium Content is available to subscribers only. Please login here to access content or go here to purchase a subscription.